SEC 13F Intelligence

Managers / Q3 2025

LASRY MARC

CIK 0001259927

Reported Value
$15M
Q3 2025
Positions
9
Filings on Record
32
2019–present window
Filed
Nov 14, 2025
original filing

Summary

Lasry Marc reported $15M in U.S.-listed holdings across 9 positions for Q3 2025.

The portfolio is heavily concentrated: Xbp Global alone accounts for 64.9% of reported value.

Compared with Q2 2025, the fund opened 3 new positions and exited 2.

Portfolio Metrics

Turnover
+75.6%
vs prior filed quarter
Largest Position
+64.9%
Xbp Global
New / Exited
3 / 2
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $454MQ4 ’18Q1 ’19: $557MQ2 ’19: $466MQ3 ’19: $306MQ4 ’19: $298MQ4 ’19Q1 ’20: $122MQ2 ’20: $152MQ3 ’20: $155MQ4 ’20: $263MQ4 ’20Q1 ’21: $145MQ2 ’21: $217MQ3 ’21: $162MQ4 ’21: $203MQ4 ’21Q1 ’22: $201MQ2 ’22: $66MQ3 ’22: $52MQ4 ’22: $64MQ4 ’22Q1 ’23: $52MQ2 ’23: $77MQ3 ’23: $101MQ4 ’23: $68MQ4 ’23Q1 ’24: $117MQ2 ’24: $101MQ3 ’24: $55MQ4 ’24: $23MQ4 ’24Q1 ’25: $22MQ2 ’25: $18MQ3 ’25: $15Mfilingsflow.com

Portfolio Composition

By security type
Other: 66.1%Common Stock: 33.9%
  • Other · 66.1% · $10M
  • Common Stock · 33.9% · $5M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
XBP GLOBAL HOLDINGS INCNEW+12.11M12.11M+$10M$10M
HYPDHYPERION DEFI INCNEW+240.1K240.1K+$2M$2M
TIVIC HEALTH SYSTEMS INCNEW+101.6K101.6K+$293,734$293,734
PDD HOLDINGS INCSOLD OUT−15.00M0−$15M$0
EXELA TECHNOLOGIES INCSOLD OUT−77.5K0−$16,275$0
BEYOND AIR INCTRIMMED−1.56M82.0K−$93,098$189,305
DRIOEURDARIOHEALTH CORPTRIMMED−441.7K23.2K+$91,830$403,318
NEXTNEXTDECADE CORPHELD+0254.3K−$539,053$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2025

9 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBP GLOBAL HOLDINGS INCCOM64.89%$10M12.11M
2HYPDHYPERION DEFI INChistory →COM NEW15.28%$2M240.1K
3NEXTNEXTDECADE CORPhistory →COM11.47%$2M254.3K
4DRIOEURDARIOHEALTH CORPhistory →COM NEW2.68%$403,31823.2K
5TIVIC HEALTH SYSTEMS INCCOM1.95%$293,734101.6K
6FRGEFORGE GLOBAL HOLDINGS INChistory →COM SHS1.28%$192,03511.4K
7BEYOND AIR INCCOM1.26%$189,30582.0K
8OBIOORCHESTRA BIOMED HLDGS INChistory →COM1.00%$150,95560.9K
9RANIRANI THERAPEUTICS HLDGS INCCOM CL A0.21%$31,43162.9K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$15M9Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$18M8Aug 15, 202513F-HRchanges · EDGAR ↗
Q1 2025$22M10May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$23M11Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$55M10Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$101M11Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$117M11May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$68M10Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$101M13Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$77M12Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$52M10May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$64M11Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$52M14Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$66M14Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$201M16May 17, 202213F-HRchanges · EDGAR ↗
Q4 2021$203M11Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$162M11Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$217M16Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$145M11May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$263M11Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$155M6Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$152M9Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$122M11May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$298M11Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$306M15Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$466M17Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$557M16May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$454M13Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • Avenue Capital Management II GenPar, LLC028-12377
  • Avenue Capital Management II, L.P.028-11224

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.